2216751-26-5
2216751-26-5 structure
- Name: Cosibelimab
- Chemical Name: Cosibelimab
- CAS Number: 2216751-26-5
- Molecular Formula:
- Molecular Weight:
- Catalog: Signaling Pathways Immunology/Inflammation PD-1/PD-L1
- Create Date: 2023-03-03 00:21:01
- Modify Date: 2025-09-04 10:18:05
-
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1+ cell lines, including lymphoma cells[1].
| Name | Cosibelimab |
|---|
| Description | Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1+ cell lines, including lymphoma cells[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |